Lawrence P. Carter, Ph.D. - Related publications

Affiliations: 
Jazz Pharmaceuticals, Palo Alto, CA, United States 
Area:
Human behavioral pharmacology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
37 most relevant papers in past 60 days:
Year Citation  Score
2021 Liu Y, Wang M, Dong X, He J, Zhang L, Zhou Y, Xia X, Dou G, Wu CT, Jin J. A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects. Pharmacology Research & Perspectives. 9: e00785. PMID 33957018 DOI: 10.1002/prp2.785   
2021 Beyerle A, Greene B, Dietrich B, Kingwell BA, Panjwani P, Wright SD, Herzog E. Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats. Toxicology and Applied Pharmacology. 422: 115557. PMID 33932462 DOI: 10.1016/j.taap.2021.115557   
2021 Groenland SL, Ratain MJ, Chen LS, Gandhi V. The Right Dose: From Phase I to Clinical Practice. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 41: 92-106. PMID 34010057 DOI: 10.1200/EDBK_319567   
2021 Axiak-Bechtel SM, Leach SB, Scholten DG, Newton-Northup JR, Johnson BJ, Durham HE, Gruber KA, Callahan MF. Pharmacokinetics and safety of TCMCB07, a melanocortin-4 antagonist peptide in dogs. Pharmacology Research & Perspectives. 9: e00777. PMID 34014033 DOI: 10.1002/prp2.777   
2021 Peters EN, Mosesova I, MacNair L, Vandrey R, Land MH, Ware MA, Turcotte C, Bonn-Miller MO. Safety, Pharmacokinetics, and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants. Journal of Analytical Toxicology. PMID 33848338 DOI: 10.1093/jat/bkab035   
2021 Bai N, Wang J, Che H, Wang H, Wang R, Cai Y. Evaluation of the Potential Effect of Iptakalim Hydrochloride on the QT Interval in Single- and Multiple-Ascending-Dose Studies Using Concentration-QTc Analysis. Clinical Pharmacology in Drug Development. PMID 33855805 DOI: 10.1002/cpdd.945   
2021 Modi NB, Cheng X, Mattheakis L, Hwang CC, Nawabi R, Liu D, Gupta S. Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. Clinical Pharmacology in Drug Development. PMID 33942566 DOI: 10.1002/cpdd.946   
2021 Nides M, Rigotti NA, Benowitz N, Clarke A, Jacobs C. A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial). Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33847362 DOI: 10.1093/ntr/ntab073   
2021 Huh KY, Choi Y, Nissel J, Palmisano M, Wang X, Liu L, Ramirez-Valle F, Lee H. Pharmacokinetics and tolerability of apremilast in healthy Korean adult men. Clinical and Translational Science. PMID 33932093 DOI: 10.1111/cts.13013   
2021 Jurczak W, Rule S, Townsend W, Tucker D, Sarholz B, Scheele J, Dyroff M, Gribben JG, Długosz-Danecka M, Zinzani PL. Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies. Leukemia & Lymphoma. 1-8. PMID 33896333 DOI: 10.1080/10428194.2021.1913139   
2021 Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, et al. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab in Chinese Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Phase 1 Study. Antimicrobial Agents and Chemotherapy. PMID 33972256 DOI: 10.1128/AAC.00350-21   
2021 Alam MM, Emon NU, Alam S, Rudra S, Akhter N, Mamun MMR, Ganguly A. Assessment of pharmacological activities of Lygodium microphyllum Cav. leaves in the management of pain, inflammation, pyrexia, diarrhea, and helminths: In vivo, in vitro and in silico approaches. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 139: 111644. PMID 33945914 DOI: 10.1016/j.biopha.2021.111644   
2021 Liu J, Scott BW, Burnham WM. Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice. Behavioural Pharmacology. PMID 33883447 DOI: 10.1097/FBP.0000000000000636   
2021 Thai C, Tayo B, Critchley D. A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects. Clinical Pharmacology in Drug Development. PMID 33951339 DOI: 10.1002/cpdd.950   
2021 Morris PJ, Burke RD, Sharma AK, Lynch DC, Lemke-Boutcher LE, Mathew S, Elayan I, Rao DB, Gould TD, Zarate CA, Zanos P, Moaddel R, Thomas CJ. A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801. Neurotoxicology and Teratology. 106993. PMID 33945878 DOI: 10.1016/j.ntt.2021.106993   
2021 da Silva GC, de Oliveira AM, de Freitas AFS, Guedes Paiva PM, Napoleão TH. Antinociceptive and anti-inflammatory effects of saline extract and lectin-rich fraction from Microgramma vacciniifolia rhizome in mice. Chemistry & Biodiversity. PMID 33893724 DOI: 10.1002/cbdv.202100125   
2021 Waidyanatha S, Mutlu E, Gibbs S, Pierfelice J, Smith JP, Burback B, Blystone CT. Phenolic benzotriazoles: a class comparison of toxicokinetics of ultraviolet-light absorbers in male rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-27. PMID 33952035 DOI: 10.1080/00498254.2021.1927239   
2021 Hampton CE, Queiroz-Williams P, Oubre MJ, Martin A, Gisclair AT, Pypendop BH. Pharmacokinetics of oral and compounded intravenous gabapentin in Duroc swine (Sus Scrofa). Journal of Veterinary Pharmacology and Therapeutics. PMID 33978255 DOI: 10.1111/jvp.12977   
2021 Wasserman S, Davis A, Stek C, Chirehwa M, Botha S, Daroowala R, Bremer M, Maxebengula M, Koekemoer S, Goliath R, Jackson A, Crede T, Naude J, Szymanski P, Vallie Y, et al. Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial. Antimicrobial Agents and Chemotherapy. PMID 33972248 DOI: 10.1128/AAC.00140-21   
2021 Cornelissen JC, Blough BE, Bohn LM, Negus SS, Banks ML. Some effects of putative G-protein biased mu-opioid receptor agonists in male rhesus monkeys. Behavioural Pharmacology. PMID 33883450 DOI: 10.1097/FBP.0000000000000634   
2021 Velzen MV, Dahan JDC, van Dorp ELA, Mogil JS, Hooijmans CR, Dahan A. Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal studies. Pain. PMID 33790195 DOI: 10.1097/j.pain.0000000000002231   
2021 Silva EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, de Souza Araújo AA, Serafini MR, Oliveira Santos LAB, Batista MVA, Viana Santos MR, Siqueira Quintans JS, Quintans-Júnior LJ, Barreto AS. Cardiovascular effects of farnesol and its β-cyclodextrin complex in normotensive and hypertensive rats. European Journal of Pharmacology. 901: 174060. PMID 33819466 DOI: 10.1016/j.ejphar.2021.174060   
2021 Auvity S, Goutal S, Caillé F, Vodovar D, Pruvost A, Wimberley C, Leroy C, Tonietto M, Bottlaender M, Tournier N. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 46: 1220-1228. PMID 33603137 DOI: 10.1038/s41386-021-00976-w   
2021 Vachhani P, Baron J, Freyer CW, Miller A, Wetzler M, Thompson JE, Griffiths EA, Wang ES. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia. Leukemia Research. 107: 106588. PMID 33957371 DOI: 10.1016/j.leukres.2021.106588   
2021 Kang SH, Lee M, Kim MY, Lee JH, Jun BG, Kim TS, Choi DH, Suk KT, Kim YD, Cheon GJ, Kim DJ, Baik SK. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study. Hepatology International. PMID 33860898 DOI: 10.1007/s12072-021-10160-3   
2021 Röpke J, Ferreira-Vieira TH, Iglesias LP, Asth L, Ribeiro FM, Moreira FA. Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia. Pharmacology, Biochemistry, and Behavior. 206: 173193. PMID 33933537 DOI: 10.1016/j.pbb.2021.173193   
2021 Gao X, Wu L, Tsai RYL, Ma J, Liu X, Chow DS, Liang D, Xie H. Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid. Pharmaceutics. 13. PMID 33920640 DOI: 10.3390/pharmaceutics13040574   
2021 Araruna ME, Silva P, Almeida M, Rêgo R, Dantas R, Albuquerque H, Cabral I, Apolinário N, Medeiros F, Medeiros A, Santos V. Tablet of L. Developed from Nebulized Extract Prevents Gastric Ulcers in Mice via Cytoprotective and Antisecretory Effects. Molecules (Basel, Switzerland). 26. PMID 33809398 DOI: 10.3390/molecules26061581   
2021 Liao MZ, Lu D, Kågedal M, Miles D, Samineni D, Liu SN, Li C. Model Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates (ADCs) in Oncology: What Can We Learn from FDA-Approved ADCs? Clinical Pharmacology and Therapeutics. PMID 33899934 DOI: 10.1002/cpt.2278   
2021 Zhong W, Chebolu S, Darmani NA. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis. European Journal of Pharmacology. 900: 174065. PMID 33775646 DOI: 10.1016/j.ejphar.2021.174065   
2021 Eap CB, Gründer G, Baumann P, Ansermot N, Conca A, Corruble E, Crettol S, Dahl ML, de Leon J, Greiner C, Howes O, Kim E, Lanzenberger R, Meyer JH, Moessner R, et al. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-68. PMID 33977870 DOI: 10.1080/15622975.2021.1878427   
2021 Borah S, Sarkar P, Sharma HK. Analysing fractions and essential oil for neuroprotective potential against anxiety, depression, and amnesia. 3 Biotech. 11: 240. PMID 33968583 DOI: 10.1007/s13205-021-02793-w   
2021 Rocha JF, Santos A, Gama H, Moser P, Falcão A, Pressman P, Hayes AW, Soares-da-Silva P. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomised, Placebo-Controlled Study in Healthy Volunteers. Clinical Pharmacology and Therapeutics. PMID 33998672 DOI: 10.1002/cpt.2290   
2021 Dhondt L, Croubels S, Temmerman R, De Cock P, Meyer E, Van Den Broeck W, De Paepe P, Devreese M. The Development of a Juvenile Porcine Augmented Renal Clearance Model Through Continuous Infusion of Lipopolysaccharides: An Exploratory Study. Frontiers in Veterinary Science. 8: 639771. PMID 33996970 DOI: 10.3389/fvets.2021.639771   
2021 Surabhi G, Dhara S, Maneesh A, Chakraborty K, Valluru L, Chenchula SR. Polygalacto-fucopyranose from marine alga as a prospective antihypertensive lead. International Journal of Biological Macromolecules. 183: 589-599. PMID 33933545 DOI: 10.1016/j.ijbiomac.2021.04.140   
2021 Bhatti UF, Remmer H, Williams AM, Biesterveld BE, Russo R, Wakam G, Kemp M, Tagett R, Liu B, Li Y, Alam HB. Assessment of the Cytoprotective Effects of High-Dose Valproic Acid Compared to a Clinically Used Lower Dose. The Journal of Surgical Research. 266: 125-141. PMID 33991999 DOI: 10.1016/j.jss.2021.03.025   
2021 Li X, Chen Y, Xu X, Li Y, Fan Y, Liu X, Bian X, Wu H, Zhao X, Feng M, Guo B, Zhang J. Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against . Frontiers in Pharmacology. 12: 658558. PMID 34017256 DOI: 10.3389/fphar.2021.658558